Case demonstrates initiation of a sodium-glucose cotransporter-2 (SGLT2) inhibitor in a patient with type 2 diabetes and heart failure. A 56-year-old man with a history of hypertension and type 2 ...
In a recent study published in the European Heart Journal, researchers assessed the impact of sodium-dependent glucose co-transporter 2 (SGLT2) inhibitors on type 2 diabetes and heart failure (HF) ...
How therapeutic advances can address all 3 conditions was the topic of a symposium Friday during the 81st Scientific Sessions of the American Diabetes Association (ADA), “The Intersection of Diabetes, ...
Please provide your email address to receive an email when new articles are posted on . Patients with heart failure who received an SGLT2 inhibitor were less likely to experience sudden cardiac death ...
Nihar R. Desai, MD, MPH, and Om P. Ganda, MD, discuss care pathways and the clinical utility of SGLT2 inhibitors and GLP-1 receptor agonists in heart failure. Neil Minkoff, MD: How do you as ...
Sodium glucose cotransporter-2 (SGLT2) inhibitors have been described as revolutionary advances in the management of patients with type 2 diabetes, particularly in people with comorbid cardiovascular ...
BARCELONA -- Starting patients on empagliflozin (Jardiance) in the acute phase of a large myocardial infarction (MI) resulted in improvements in surrogate markers of heart failure (HF) and heart ...
Patients with heart failure with reduced ejection fraction (HFrEF) may increase their lifespan if they take the SGLT2 inhibitor dapagliflozin (Farxiga) over the long term, a statistical modeling study ...
Hosted on MSN
SGLT2 inhibitor treatment stabilizes kidney function in patients who have had a heart attack
SGLT2 inhibitors have become a major drug used to treat diabetes, heart failure, and chronic kidney disease. However, there have been questions as to whether it is safe to use these drugs in patients ...
EMPACT-MI is the first analysis to determine if it is safe with respect to the kidney to initiate SGLT2 inhibitors in patients during or soon after hospitalization for acute MI. The researchers ...
Please provide your email address to receive an email when new articles are posted on . SGLT2 inhibitors may directly or indirectly impact factors associated with diabetes and atrial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback